Para poder acceder a la web de la GT debes tener el código de registro de la 8a edición de la Guía. No son válidos los códigos de ediciones anteriores. Si no has registrado tu código, debes hacerlo aquí.

Registrarse

¿Has olvidado la contraseña?

Para cualquier consulta o incidencia, puedes contactarnos a través del correo guiaterapeutica@semfyc.es

Problemas de la conducta y de la relación

  • Bighelli I Castellazzi M, Cipriani A, Girlanda F, Guaiana G, Koesters M, Turrini G. et al. Antidepressants versus placebo for panic disorder in adults Cochrane Systematic Review - Intervention Version published: 05 April 2018.
  • Grupo de Trabajo de la Guía de Práctica Clínica para el Manejo de Pacientes con Insomnio en Atención Primaria. Guía de Práctica Clínica para el Manejo de Pacientes con Insomnio en Atención Primaria. Plan de Calidad para el Sistema Nacional de Salud del Ministerio de Sanidad y Política Social. Unidad de Evaluación de Tecnologías Sanitarias. Agencia Laín Entralgo. Comunidad de Madrid; 2009. Guías de Práctica Clínica en el SNS: UETS Nº 2007/5-1. Disponble en: http://www.guiasalud.es/GPC/GPC_465_Insomnio_Lain_Entr_compl.pdf.
  • Grupo de Trabajo sobre el Manejo de la Depresión Mayor en el Adulto. Guía de Práctica Clínica sobre el Manejo de la Depresión Mayor en el Adulto. Madrid: Plan Nacional para el SNS del MSC. Axencia de Avaliación de Tecnoloxías Sanitarias de Galicia (avalia-t); 2008. Guías de Práctica Clínica en el SNS: avalia-t Nº 2006/06 Disponible en: http://www.guiasalud.es/GPC/GPC_424_Dep_Adult_compl.pdf
  • Hall-Porter Jk, Walsh JK. Pharmacologic Treatment of Primary Insomnia. Sleep Med Clin. 2010:5:609-25.
  • Hoge EA, Ivkovic A, Fricchione GL. Generalized anxiety disorder: diagnosis and treatment. BMJ. 2012;345:37-42
  • Judd FK, et al. Depression and midlife: Are we overpathologising the menopause? J Affect Disord. 2011:doi.10.1016/j.jad.2010.12.010.
  • Katzman MA, Bleau P, Blier P, Chokka P, Kjernisted K, Van Ameringen M. Canadian clinical practice guidelines for the management of anxiety, posttraumatic stress and obsessive-compulsive disorders BMC Psychiatry 2014, 14(Suppl 1):S1
  • Lampe L. Drug treatment for anxiety. Aust Prescr. 2013;36:186-9.
  • Martín García-Sancho J. Guía de práctica clínica para el tratamiento de la esquizofrenia en centros de salud mental . Servicio Murciano de Salud 2009.
  • Michel J, Dugas MJ, Brillon P, Savard P, Turcotte J, Gaudet A, Ladouceur R, Leblanc R, Gervais NJ. A Randomized Clinical Trial of Cognitive-Behavioral Therapy and Applied Relaxation for Adults With Generalized Anxiety Disorder. Behavior Therapy. 2010; 41: 46-58
  • San Molina L, Bernardo Arroyo M, Arrojo Romero M, Arranz Marti B, Becoña E, Caballero L, Castells X.Guía de Práctica Clínica para el tratamiento farmacológico y psicológico de los pacientes con un trastorno mental grave y un trastorno por uso de sustancias Guia salud 2017. Disponible en: http://portal.guiasalud.es/web/guest/catalogo-gpc?p_p_id=EXT_7_INSTANCE_OJR1&p_p_lifecycle=0&p_p_state=maximized&p_p_mode=view&_EXT_7_INSTANCE_OJR1_struts_action=%2Fext%2Fespecifico%2Fvista_Previa&_EXT_7_INSTANCE_OJR1_contenidoId=173905&_EXT_7_INSTANCE_OJR1_version=1.1
  • Smiga SM, Elliott GR. Psychopharmacology of Depression in Children and Adolescents. Pediatr Clin N Am. 2011;58:155-71.
  • Sockol L, Epperson CN, Barber JP. A meta-analysis of treatments for perinatal depression. Clinical Psychology Review. 2011;31:839-49.
  • Stroup TS, Lieberman JA, McEvoy JP, Swartz MS, Davis SM, Capuano G, et al, for the CATIE Investigators (2007). Effectiveness of Olanzapine, Quetiapine, and Risperidone in Patients with Chronic Schizophrenia after Discontinuing Perphenazine: A CATIE Study. American Journal of Psychiatry;164:415-27.
  • Tandon R, Henry A, Nasrallah H, Keshavan MS. Schizophrenia, "Just the Facts" 5. Treatment and prevention Past, present, and future. Schizophrenia Research. 2011;122:1-23.
  • Zhang Y, Zhou x, Pu J, Zhang H, Yang L, Liu L Zhou CH et al. Antidepressants for depressive disorder in children and adolescents: a database of randomised controlled trials BMC Psychiatry (2018) 18:162. Disponible en: https://doi.org/10.1186/s12888-018-1749

Ansiedad generalizada

  • Allgulander C. Novel approaches to treatment of generalized anxiety disorder. Current Opinion in Psychiatry. 2010;23:37-42.
  • Baldwin D, Woods R. Efficacy of drug treatments for generalised anxiety disorder: systematic review and meta-analysis. BMJ. 2011;342:d1199. Disponible en: http://www.bmj.com/content/342/bmj.d1199.full
  • Bunmi O, Olatunji B, Cisler JM, Descon BJ. Efficacy of Cognitive Behavioral Therapy for Anxiety Disorders: A Review of Meta-Analytic Findings. Psychiatr Clin N Am. 2010;33:557-77.
  • Bystritsky A. Pharmacotherapy for generalized anxiety disorder in adults UpToDate Aug 2018.
  • Donovan MR, Glue P, Kolluri S, Emir B. Comparative efficacy of antidepressants in preventing relapse in anxiety disorders - A meta-analysis. J Affect Disord. 2010:123:9-16.
  • Kapczinski F, dos Santos Souza JJSS, Batista Miralha da Cunha AABC, Schmitt RRS. Antidepressants for generalised anxiety disorder (GAD).Cochrane Database of Systematic Reviews 2016, Issue 3. Art. No.: CD003592.
  • Management of anxiety (panic disorders with or without agarophobia, and generalised anxiety disorders) in adults in primary, secondary and community care. Disponible en: http://www.nice.org.uk/nicemedia/pdf/CG022NICEguidelineamended.pdf
  • Martin JL, Sainz-Pardo M, Furukawa TA, Martín-Sánchez E, Seoane T, Galán C. Benzodiazepines in generalized anxiety disorder: heterogeneity of outcomes based on a systematic review and meta-analysis of clinical trials. Psychopharmacol. 2007 Sep;21(7):774-82.

Brote esquizofrénico. Esquizofrenia

  • Abidi S, Mian I, Garcia-Ortega I, Lecomte T, Raedler T, Jackson K, Jackson K et alCanadian Guidelines for the Pharmacological Treatment of Schizophrenia Spectrumand Other Psychotic Disorders inChildren and Youth The Canadian Journal of Psychiatry / 2017, Vol. 62(9) 635-647.
  • Aripiprazole for the treatment of schizophrenia in people aged 15 to 17 years. Disponible en: www.nice.org.uk/guidance/TA213
  • Barbui C, Accordini S, Nosè M, Stroup S, Purgato M, Girlanda F, et al. Aripiprazole Versus Haloperidol in Combination With Clozapine for Treatment-Resistant Schizophrenia in Routine Clinical Care: A Randomized, Controlled Trial. Journal of Clinical Psychopharmacology. 2011;31(3):266-73.
  • Claudia Leucht C, Heres S, Kane JM, Kissling W, Davis JM, Leucht S. Oral versus depot antipsychotic drugs for schizophrenia-A critical systematic review and meta-analysis of randomised long-term trials. Schizophrenia Research. 2011;127;83-92.
  • Elkis H, Buckley PF. Treatment-Resistant Schizophrenia. Psychiatric Clinics of North America, 2016;39,2:239-265.
  • Lepping P, Sambhi RS, Whittington R, Lane S, Poole R. Clinical relevance of findings in trials of antipsychotics: systematic review. The British Journal of Psychiatry. 2011;198:341-5.
  • Maher AR, Maglione M, Bagley S, Suttorp M, Hu JH, Ewing B, et al. Efficacy and comparative effectiveness of atypical antipsychotic medications for off-label uses in adults: a systematic review and meta-analysis. JAMA. 2012;307(2):147.
  • McEvoy JP, Lieberman JA, Perkins DO, Hamer RM, Gu H, Lazarus A, et al. Efficacy and tolerability of olanzapine, quetiapine, and risperidone in the treatment of early psychosis: a randomized, double-blind 52-week comparison. Am J Psychiatry. 2007 Jul;164(7):1050-60.
  • Nucifora F, Worznica E, Lee BJ, Cascella N, Sawa A.Treatment resistant schizophrenia: Clinical, biological, and therapeutic perspectives . Neurobiology of disease. .Article in press. Disponible en: https://doi.org/10.1016/j.nbd.2018.08.016
  • Off-Label Use of Atypical Antipsychotics: An Update Executive summary. Disponible en: http://www.effectivehealthcare.ahrq.gov/ehc/products/150/786/CER43_Off-LabelAntipsychotics_execsumm_20110928.pdf
  • What’s ‘atypical’ about the newer antipsychotics? National Prescribing Service 2007. Disponible en: http://www.nps.org.au/resources/NPS_News/news51/news51.pdf
  • Samara M, Klupp E, Helfer B, Rothe P, Schemeider-Thoma J, Leucht S. Increasing antipsychotic dose for non response in schizophrenia. Cochrane Database of Systematic Reviews. May 2018.
  • Stroup TS, Marder S. Pharmacotherapy for schizophrenia: Acute and maintenance phase treatment - UpToDate Aug 2018
  • Vanasse A, Blais L, Courteau J, Cohen AA, Roberge P, Larouche A, Grignon S, Fleury M-J, Lesage A, Demers M-F, Roy M-A, Carrier J-D, Delorme A. Comparative effectiveness and safety of antipsychotic drugs in schizophrenia treatment: a real-world observational study. Acta Psychiatr Scand 2016: 134: 374–384.

Depresión mayor

  • Algoritmo de tratamiento de la depresion en atencio primaria. CADIME 2015 . Disponible en: http://www.cadime.es/docs/algoritmos/CADIME_ALGORITMO_DEPRESION_2015.pdf
  • Antidepressant use and risk of adverse outcomes in older people: population based cohort study. BMJ. 2011;343:d455.
  • Ciechanowski P. Unipolar major depression in adults: Choosing initial treatment. UpToDate 2015.
  • Cipriani A, La Ferla T, Furukawa A, Signoretti A, Churchill R, McGuire H, et al. Sertraline versus other antidepressive agents for depression. Cochrane Database Syst Rev. 2010;14;(4):CD006117.
  • Coupland CAC, Dhiman P, Barton G, Morriss R, Arthur A, Sach T, Hippisley-Cox J. A study of the safety and harms of antidepressant drugs for older people: a cohort study using a large primary care database. Health Technology Assessment. 2011;15:No 28.
  • Depresión: ISRS frente a antidepresivos posteriores de 2a generación. CADIME 2016. Disponible en: http://dx.doi.org/10.11119/BTA2016-31-02
  • Depression: Management of depression in primary and secondary care. Disponible en: http://www.nice.org.uk/nicemedia/pdf/CG23fullguideline.pdf
  • García-Herrera Pérez Bryan JM, Nogueras Morillas V, Muñoz Cobos F, Morales Asencio JM. Guía de práctica clínica para el tratamiento de la depresión en Atención Primaria. Distrito Sanitario Málaga-UGC Salud Mental Hospital Regional Universitario “Carlos Haya”. Málaga. 2011.
  • Gartlehner G, Hansen RA, Morgan LC, Thaler K, Lux L, Van Noord M, et al. Comparativerative Benefits and Harms of Second-Generation Antidepressants for Treating Major Depressive Disorder. An Updated Meta-analysis. Ann Intern Med. 2011;155:772-85.
  • Qaseem A, Barry M, Kansangara D. Nonpharmacologic Versus Pharmacologic Treatment of Adult Patients With Major Depressive Disorder: A Clinical Practice Guideline From the American College of Physicians Ann Intern Med. 2016;164(5):350-359.
  • Simon G. Unipolar major depression in adults: Choosing initial treatment UpToDate. Aug 2018.

Distimia

  • Cristea IC, Huibers M, David D, Hollon SD, Anderson G, Cuijpers P. The effects of cognitive behavior therapy for adult depression on dysfunctional thinking: A meta-analysis Clinical Psychology Review 42 (2015) 62–71 .
  • Cuijpers P, van Straten A, Schuurmans J, van Oppen P, Hollon SD, Anderson G. Psychotherapy for chronic major depression and dysthymia: A meta-analysis. Clinical Psychology Review. 2010;30:51-62.
  • Jobst A, Brakemeier A, Caspar F, Cuijpers P, Ebmeier P, Falkai P, Jan van der Gaag R et all. European Psychiatric Association Guidance on psychotherapy in chronic depression across Europe . European Psychiatry 33 (2016) 18–36
  • MacQueen G, Santaguida P, Keshavarz H, Jaworska N, Levine M, Beyene J, Raina P. Systematic Review of Clinical Practice Guidelines for Failed Antidepressant Treatment Response in Major Depressive Disorder, Dysthymia, and Subthreshold Depression in Adults. The Canadian Journal of Psychiatry / La Revue Canadienne de Psychiatrie 2017, Vol. 62(1) 11-23.
  • Von Wolff A, Holzel LP , Westphal A, Harter M, Kriston L. Selective serotonin reuptake inhibitors and tricyclic antidepressants in the acute treatment of chronic depression and dysthymia: A systematic review and meta-analysis Journal of Affective Disorders 144 (2013) 7–15.

Estado confusional agudo. Delirium

  • Flaherty Jh. The Evaluation and Management of Delirium Among Older Persons. Med Clin N Am. 2011;195:555-77.
  • Fong TG; Hshieh TT; Inouye SK, Delirium in Older Persons: Advances in Diagnosis and Treatment.. JAMA 2017;26; 318 (12), pp. 1161-1174;
  • Grover S, et al. Comparative efficacy study of haloperidol, olanzapine and risperidone in delirium. J Psychosom Res. 2011. doi:10.1016/j.jpsychores.2011.01.019. [Article In Press.]
  • Shen Y, Peng K, Zhang J, Meng X, Ji F. Haloperidol on Delirium in Adult Patients: A Systematic Review and Meta-Analysis. Med Princ 2018 Jul; 27(3): 250–259.

Fobia social

  • Blanco C, Heimberg RG, Schneier FR, Fresco DM, Chen H, Turk CL, et al. A placebo-controlled trial of phenelzine, cognitive behavioral group therapy, and their combination for social anxiety disorder. Arch Gen Psychiatry. 2010;67(3):286-95.
  • Canton J, Scott KM, Glue P. Optimal treatment of social phobia: systematic review and meta-analysis. Neuropsychiatric Disease and Treatment. 2012:8;203-15.
  • De Menezes GB, Coutinho ES, Fontenelle LF, Vigne P, Figueira I, Versiani M. Second-generation antidepressants in social anxiety disorder: meta-analysis of controlled clinical trials. Psychopharmacology (Berl). 2011 May;215(1):1-11.
  • Swinson R, McCabe R. Pharmacotherapy for specific phobia in adults. Up ToDATE. Aug 2018.
  • Taylor C, Alden LE. Relational treatment strategies increase social approach behaviors in patients with Generalized Social Anxiety Disorder. Journal of Anxiety Disorders. 2011:25;309-18.
  • Williams T, Hattingh CJ, Kariuki CM, Tromp SA, van Balkom AJ, Ipser JC, Stein DJ. Pharmacotherapy for social anxiety disorder (SAnD).Cochrane Database of Systematic Reviews 2017, Issue 10. Art. No.: CD001206.

Insomnio

  • Algoritmo de retirada de benzodiacepinas (BZD)e hipniticos. CADIME 2014. Disponible en: http://www.cadime.es/docs/algoritmos/CADIME_Algoritmo%20retirada%20benzodiazepinas.pdf.
  • Belleville G, Cousineau E, Levrier K, St-Pierre-Delorme ME. Meta-analytic review of the impact of cognitive-behavior therapy for insomnia on concomitant anxiety. Clinical Psychology Review. 2011;31:638-52.
  • Everitt H, Baldwin DS, Stuart B, Lipinska G, Mayers A, Malizia AL, Manson CCF, Wilson S. Antidepressants for insomnia in adults.Cochrane Database of Systematic Reviews 2018, Issue 5. Art. No.: CD010753.
  • Pons JMV. La melatonina exògena en els trastorns del son: eficàcia i seguretat. Barcelona: Agència de Qualitat i Avaluació Sanitàries de Catalunya. Departament de Salut. Generalitat de Catalunya; 2017. Disponible en: http://aquas.gencat.cat/web/.content/minisite/aquas/publicacions/2017/melatonina_trastorns_son_aquas2017.pdf
  • Siebern A, Manber R. Insomnia and Its Effective Non-pharmacologic Treatment. Med Clin N Am. 2010;94:581-91.
  • Winkelman JW. Overview of the treatment of insomnia in adults - UpToDate Aug 2018.

Trastorno bipolar

  • Amsterdam J, Shults J. Efficacy and Safety of Long-Term Fluoxetine Versus Lithium Monotherapy of Bipolar II Disorder: A Randomized, Double-Blind, Placebo-Substitution Study. Am J Psychiatry. 2010 Jul;167(7):792-800.
  • Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) 2018 guidelines for the management of patients with bipolar disorder. Yatham LN, Kennedy SH, Parikh S, Schaffer A, Bond DJ, Frey BN, Sharma V. Bipolar Disorders. 2018;20:97–170.
  • Castro-Loli P, Colom F, Murru A, Pacchiarotti I, González-Pinto A, Fountoulakis K, et al. New treatment guidelines for acute bipolar depression: A systematic review. J Affect Disord. 2011;129:14-26.
  • De Fazio P, Gaetano R, Caroleo M, Pavia M, De Sarro G, Fagiolini, Segura-Garcia C. Lithium in late-life mania: a systematic review Neuropsychiatric Disease and Treatment 2017:13 755–766.
  • Pilhatsch M, Wolf R, Winter C, Lewitka U, Bauer M. Comparison of paroxetine and amitriptyline as adjunct to lithium maintenance therapy in bipolar depression: A reanalysis of a randomized,double-blind study. Journal of Affective Disorders. 2010;126: 453-457.
  • Severus E, Schaaff N, Hans-Moller J. State of the Art: Treatment of Bipolar Disorders. CNS Neuroscience & Therapeutics. 2012;18:214-8.
  • Stovall J. Bipolar disorder in adults: Choosing pharmacotherapy for acute mania and hypomania - UpToDate Aug 2018.
  • Treatment of bipolar disorder: A focus on medication therapy for mania. Formulary. 2011;46:82-97 . Disponible en: http://formularyjournal.modernmedicine.com/formulary/Modern+Medicine+Now/Treatment-of-bipolar-disorder-A-focus-on-medicatio/ArticleStandard/Article/detail/712312.

Trastorno obsesivo compulsivo

  • Decloedt EH, Stein DJ. Current trends in drug treatment of obsessive-compulsive disorder. Neuropsychiatr Dis Treat. 2010;6:233-42.
  • Fenske JL, Schwenk TL. Obsessive-Compulsive Disorder: Diagnosis and Management. Am Fam Physician. 2009;80(3):239-45.
  • Kellner M Drug treatment of obsessive-compulsive disorder. Dialogues Clin Neurosci. 2010;12(2):187-97.
  • Marazziti D, Consoli G. Treatment strategies for obsessive-compulsive disorder. Expert Opin Pharmacother. 2010 Feb;11(3):331-43.
  • McGuire JF, Lewin AB, Horng B, Murphy TK, Storch EA. The nature, assessment, and treatment of obsessive-compulsive disorder. Postgrad Med. 2012;124(1):152-65.

Trastorno de pánico. Crisis de angustia

  • Bighelli I, Trespidi C, Castellazzi M, Cipriani A, Furukawa TA, Girlanda F, Guaiana G, Koesters M, Barbui C. Antidepressants and benzodiazepines for panic disorder in adults. Cochrane Database of Systematic Reviews 2016.
  • Freire R.C., Zugliani M.M., Garcia R.F., Nardi A.E .Treatment resistant panic disorder: A systematic review. Expert Opinion on Pharmacotherapy 2016 17:2 (159).
  • Generalised anxiety disorder and panic disorder (with or without agoraphobia) in adults: management in primary, secondary and community care (partial update) 2010. Disponible en: http://www.nice.org.uk/nicemedia/live/12147/49816/49816.pdf
  • Moylan S, Staples J, Ward SA, Rogerson J, Stein DJ, Berk M. The efficacy and safety of alprazolam versus other benzodiazepines in the treatment of panic disorder. J Clin Psychopharmacol. 2011;(5):647-52.